Results 81 to 90 of about 339,257 (237)

Identification of symptom clusters in patients with chronic venous leg ulcers [PDF]

open access: yes, 2014
Context\ud \ud Patients with venous leg ulcers experience multiple symptoms, including pain, depression, and discomfort from lower leg inflammation and wound exudate. Some of these symptoms impair wound healing and decrease quality of life (QOL).
Alexander, Kimberly   +6 more
core   +1 more source

Four Layer Bandage Versus Two Layer Bandage in Management of Venous Leg Ulcers [PDF]

open access: yesZagazig University Medical Journal
Background: Venous leg ulcers are the most prevalent kind of leg ulcers. The key to managing venous ulcers is lowering ambulatory venous hypertension (AVH), which lowers edema and inflammation in the leg and, if kept at optimal venous pressure, promotes ...
Hossam Tawfeek   +3 more
doaj   +1 more source

Comparing outcomes using low‐dose apixaban and anti‐Xa monitoring and vitamin K antagonists in patients with renal replacement therapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Background Guidelines recommend oral anticoagulation for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Outside the United States, apixaban is unlicensed for use in patients with end‐stage renal disease (ESRD) receiving renal replacement therapy (RRT).
John K. Bartoli‐Abdou   +10 more
wiley   +1 more source

Rétrograde venous perfusion (RVP) for intraçtable venous leg ulcers: a retrospective analysis

open access: yesEuropean Journal of Medical Research
Background Retrograde venous perfusion (RVP) is a minimally invasive procedure in which the limb circulation is isolated by the application of a proximal limb tourniquet, followed by the administration of specific medications through a distal limb vein ...
Alaa Sharabi   +6 more
doaj   +1 more source

EXPERIENCES CONSTRUCTED IN THE PROCESS OF LIVING WITH A VENOUS ULCER

open access: yesCogitare Enfermagem, 2015
The aim of this study was to identify the experiences constructed by people with venous ulcers, in the process of living with this chronic condition. This qualitative study was conducted between January and February 2013.
Dalva Cezar da Silva   +5 more
doaj   +1 more source

A Crackling Venous Ulcer [PDF]

open access: yesEuropean Journal of Vascular and Endovascular Surgery, 2020
Melina, Vega de Ceniga   +1 more
openaire   +2 more sources

Comparative treatment effects of direct oral anticoagulants versus warfarin for nonvalvular atrial fibrillation in clinical practice vary over time due to channelling

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Temporal shifts in patient characteristics can influence comparative treatment effects within a certain indication. We investigated patient characteristics and comparative effectiveness and safety for direct oral anticoagulants (DOACs) and warfarin over the time period where DOACs replaced warfarin as preferred stroke prophylaxis in patients with ...
Raoul B. L. J. van den Hemel   +6 more
wiley   +1 more source

Photodynamic therapy for chronic venous ulcers [PDF]

open access: yes, 2014
Some laboratory findings and a few case reports support the treatment of chronic venous ulcers with photodynamic therapy. We treated 19 patients with refractory chronic venous ulcers using photodynamic therapy. The ulcers healed in 15 cases (78.9%) after
Cappugi, Pietro   +2 more
core   +1 more source

What's new: Management of venous leg ulcers Treating venous leg ulcers

open access: yes, 2016
Venous leg ulcers account for approximately 70% of all leg ulcers and affect 2.2 million Americans annually. After a comprehensive patient and wound assessment, compression therapy remains the cornerstone of standard care.
Sibbald, R. Gary   +11 more
core   +1 more source

Sequential catalytic nanosystem of carbon dots and uricase integrated with polydopamine for therapy of gouty wound ulceration

open access: yesBMEMat, EarlyView.
Sequential dual‐catalytic treatment of the gout wound ulceration process by CDs‐Uri@PDA. (a) Synthesis steps and morphology of CDs‐Uri@PDA. (b) Sequential treatment process and mechanism of CDs‐Uri@PDA for gout wound ulceration according to (i) uric acid reduction, (ii) antibacterial activity, and (iii) anti‐inflammatory effects.
Yonglan Yang   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy